Zdrowie i gospodarka · 07/01/2025
FDA Releases Draft Guidance on Using Artificial Intelligence for Drug and Biological Product Regulation
The FDA has released a draft guidance to help the pharmaceutical industry use artificial intelligence to support regulatory decision-making for drug and biological products, aiming to improve public health.